OBJECTIVE: To determine the effects of weight variability on cardiovascular risk factors. DESIGN: Longitudinal study (followed from 1990 to 1998). SUBJECTS: Five-hundred and eighty nonsmoking Japanese male of®ce workers aged 25 ± 49 y. MEASUREMENTS: Baseline levels and slopes of seven selected cardiovascular risk factors (systolic and diastolic blood pressure, total and high-density lipoprotein cholesterol, triglyceride, uric acid and hemoglobin A 1c ) and body mass index (BMI) variables (baseline BMI, BMI-slope, the root mean square error (BMI-RMSE), and the BMI-slopeÂBMI-RMSE interaction). RESULTS: From the multiple regression analyses, the slopes of the six cardiovascular risk factors, except hemoglobin A 1c , were most strongly related to the baseline level of each cardiovascular risk factor and BMI-slope. Neither BMI-RMSE nor the interaction of BMI-RMSE with BMI-slope was related to these cardiovascular risk factor slopes. As for hemoglobin A 1c , BMI-slope and the interaction of BMI-RMSE with BMI-slope were not signi®cantly related to hemoglobin A 1c slope but baseline BMI and BMI-RMSE were. Furthermore, hemoglobin A 1c slope values were signi®cantly higher among those who cycled at b4.0 kg than among those who did not. CONCLUSION: The only cardiovascular risk factor associated with BMI variability was hemoglobin A 1c . Weight variability had less or little impact on cardiovascular risk factors compared with BMI-slope and baseline BMI.
Introduction
The long-term effects of weight variability on allcause mortality and mortality from cardiovascular disease have been reported. Some authors have reported positive relationship of weight variability with an increase in all-cause mortality, 1 ± 5 while others have not. 6, 7 On the other hand, a relationship between weight variability and mortality from cardiovascular disease is fairly consistent, and re¯ects relative risks of 1.25 ± 2.0 across studies 1 ± 6 for high levels of¯uctuation.
To investigate the health effects of weight variability, several cross-sectional or longitudinal studies examined the relationship between weight variability and changes in cardiovascular risk factors. As for blood pressure, one study 8 found that obese patients with a history of weight cycling had smaller reductions in systolic and diastolic blood pressure in response to a very-low-calorie diet than did noncycling obese patients, but others 7, 913 found no associations between cycling history and blood pressure. Relatively little work has been done on serum lipids, but evidence thus far suggests no link between weight variability and serum cholesterol levels. 7, 913 As for glucose tolerance, longitudinal studies 7, 14 found that weight variability was associated with greater decreases in glucose tolerance and increased rate of diabetes, but other studies have found no relationship between weight cycling and fasting glucose values 9 ± 11 or between metabolic control and need for hypoglycemic medication in diabetes. 15 Data at present do not allow us to determine whether there are clear links between weight variability and cardiovascular risk factors.
Given the possibility that variability in body weight may increase cardiovascular mortality, and the sparse information available on the effects of weight cycling on cardiovascular risk factors, it is important to examine the effects of body weight variability in a variety of populations. In this report on a longitudinal population study based on annual health examinations at the workplace, we have tried to determine the effects of weight variability on cardiovascular risk factors among nonsmoking middle-aged Japanese male of®ce workers.
Materials and methods

Subjects
The longitudinal sample (followed from 1990 to 1998) of the T corporation, which is one of the biggest building contractors in Osaka, was used in this analysis. All Japanese male of®ce workers aged 25 ± 49 y in May 1990 were invited to participate in a survey (n 1609), and the participation rate was 100.0%.
Height and weight were measured at every examination in May 1990 ± 1998. Height in standing position (to the nearest 0.5 cm) was measured and weight (to the nearest 0.5 kg) was measured using a calibrated platform scale. Subjects were measured in light clothing and without shoes. Body mass index (BMI) was calculated as weightaheight 2 (kgam 2 ) and was used as the index for relative weight. Blood pressure was measured to the nearest 2 mmHg with a standard sphygmomanometer on the right arm of subjects sitting after 5 min rest. Korotkoff phases I and V were taken to represent systolic and diastolic blood pressure, respectively. After the measurement of blood pressure and while the participant was fasting, blood samples were drawn from an antecubital vein. Total cholesterol, high-density lipoprotein (HDL) cholesterol, triglyceride and uric acid were determined with an Olympus AU-5000 in 1990 ± 1994 and an Olympus AU-5200 in 1995 ± 1996 (Olympus Japan Co. Ltd, Tokyo, Japan) by the Nihon Clinical Laboratories Inc. (Tokyo, Japan). Hemoglobin A 1c was determined with an automated glycohemoglobin analyzer system HS-8 (Jookoo Co. Ltd, Tokyo, Japan). Quality control of the laboratory was maintained internally by the use of pooled serum, and the inter-and intra-assay coef®cients of variation for blood samples were within 3% from 1990 to 1998. Of a total of 1609 subjects, follow-up until May 1998 could be completed for only 1373 subjects (85.3%), and data on BMI and cardiovascular risk factors for nine consecutive years were available for 1326 subjects (96.6%). Of 1326 subjects, 666 continuous or intermittent smokers (50.2%) during the follow-up period were excluded because change in smoking status affects weight. 16, 17 Of 660 nonsmokers during the follow-up period, 36 (5.5%) took prescription medication for hypertension, dyslipidemia, hyperuricemia or diabetes mellitus at entry. Forty-four subjects began to use medical drugs for respective diseases or disorders during the follow-up period. The remaining 580 subjects constituted the study population. Table 1 shows characteristics of cardiovascular risk factors in 580 nonsmoking men, 1990 ± 1998.
BMI variability and slope
BMI was used for analyses instead of weight, because BMI is less correlated with height. BMI variability can be separated into two distinct components: trend over time and variability (weight cycling) over time.
To separate the components of BMI trend and BMI variability, we used a simple linear regression model. Each individual's nine BMI values were regressed on the time of survey. The slope coef®cient of this model was used to represent an individual's BMI trend, while the root mean square error (BMI-RMSE) of this model was used to measure the variability about the line, or BMI variability. Slopes for cardiovascular risk factors were calculated similarly. The coef®cient of variation of BMI is commonly used to describe weight¯uctuation, but a person who has a slight, steady weight gain over a long period of time can have the same coef®cient of variation as a person who has large weight gains and losses with no overall weight gain. 18 Because coef®cient of variation and slope are correlated, one cannot determine whether signi®cant coef®cient-of-variation terms are detecting a nonlinear slope effect or instability. By contrast, BMIslope and BMI-RMSE are uncorrelated; hence, BMI-RMSE can be considered a more pure measure of instability regardless of overall trend.
12,19
Statistical analysis
To examine the association between the BMI variables and changes in cardiovascular risk factors, Pearson correlations were calculated. To examine which of the BMI variables were most strongly related to risk factor change, we ®tted a multiple linear regression model. The slope of each cardiovascular risk factor was used as the dependent variable, and the independent variables were the baseline levels of the cardiovascular risk factor, age and BMI, BMI-slope, Weight variability and cardiovascular risk factors N Nakanishi et al BMI-RMSE, and the BMI-slopeÂBMI-RMSE interaction. In the statistical analyses, the natural (base e) logarithm for the triglyceride (because of the non gaussian distribution of the frequency for this variable) was used.
To compare weight cyclers with noncyclers in a manner that other studies have used, 10, 12 we compared persons who cycled at b4.0 kg with those who did not. If a person had a loss (or gain) of over 4.0 kg between two consecutive surveys and was later observed to have a gain (or loss) of over 4.0 kg between two consecutive surveys, he was considered a weight cycler. Analysis of variance was used to compare the means of cardiovascular risk factor slopes between cyclers and noncyclers. Table 2 shows mean values for age and variables related to BMI in 580 nonsmoking men. The correlations among these variables are shown in Table 3 . Age was signi®cantly correlated with baseline BMI and BMI-slope. BMI at baseline was signi®cantly correlated with BMI-slope and BMI-RMSE. BMI-slope was not correlated with BMI-RMSE, as predicted, which suggests that these two variables measure different things. Table 4 shows the bivariate correlations between changes in seven cardiovascular risk factors (using the slope of each risk factor as a measure of change) and age and BMI variables. Changes in systolic and diastolic blood pressure, total cholesterol, HDL cholesterol, log triglyceride and uric acid were most strongly correlated with BMI-slope. The largest correlation was the correlation between BMI-slope and log triglyceride slope (r 0.452), indicating that those with steeper BMI gains would have steeper triglyceride gains. Those with a steeper BMI-slope tended to have steeper increases of diastolic blood pressure, total cholesterol and uric acid (r b0.2) and steeper decreases of HDL cholesterol (r 70.268). On the other hand, correlations of cardiovascular risk factor change with age, baseline BMI, and BMI-RMSE were all quite small for these six cardiovascular risk factors. As for hemoglobin A 1c , the slope was not related to BMI-slope but was signi®cantly positively correlated with baseline BMI and BMI-RMSE. Table 5 shows the results of multiple regression analyses between changes in cardiovascular risk factors and age and weight related variables. The slopes of the six cardiovascular risk factors, except hemoglobin A 1c , were most strongly related to the baseline level of each variable and BMI-slope. BMI-slope was not signi®cantly related to hemoglobin A 1c slope but baseline BMI was. Age was related to systolic blood pressure slope and log triglyceride slope, and baseline BMI was related to HDL cholesterol slope and hemoglobin A 1c . As for BMI-RMSE, there was a weak but signi®cant association between hemoglobin A 1c slope and BMI-RMSE.
Results
To examine the effects of weight cycling on cardiovascular risk factors, we compared 36 men who cycled at b4.0 kg with 544 who did not. There were no signi®cant differences for the slope values of systolic and diastolic blood pressure, total cholesterol, HDL cholesterol, log triglyceride and uric acid. On the other hand, there were signi®cant differences (P 0.002, analysis of variance) among hemoglobin A 1c slope values between two groups (0.004 AE 0.075%ay for noncyclers and 0.048AE ; RMSE, root mean square error; HDL, high-density cholesterol.
Weight variability and cardiovascular risk factors N Nakanishi et al 0.156%ay for cyclers, mean AE s.d.). The signi®cant differences in hemoglobin A 1c slopes remained after controlling for hemoglobin A 1c , age and BMI at baseline (P 0.012).
Discussion
We found no evidence from a middle-aged Japanese population that weight variability was associated with increased levels of systolic and diastolic blood pressure, total cholesterol, HDL cholesterol, log triglyceride and uric acid. Our ®ndings are consistent with results of other studies. 7,9 ± 13 As for the relationship between weight variability and glucose tolerance and diabetes, a large longitudinal study of aging has found that weight variability over time is associated with greater decreases in glucose tolerance. 7 In another longitudinal study with 2000 adults, weight¯uctua-tion between the ages of 40 and 60 y was associated with a signi®cantly increased rate of diabetes.
14 This study also provides evidence that weight variability might be associated with increased hemoglobin A 1c levels. Furthermore, we demonstrated that baseline BMI was signi®cantly positively associated with changes in hemoglobin A 1c . These results suggest that individuals with greater baseline BMI and BMI variability would have steeper increases in hemoglobin A 1c levels. A potential explanation for the positive ®nding is that change in hemoglobin A 1c during weight gain may not be fully reversible with the subsequent weight loss, eg atherogenic progression. An increase in hemoglobin A 1c resulting from BMI variability might play a role in the adverse cardiovascular outcomes. Further study is necessary to clarify the in¯uence of cardiovascular risk factors, eg population characteristics, de®nition of cycling, and motivation of weight loss, which may distort the effects of weight variability.
Although not central to this analysis, it may be noted that the regression coef®cients (b) for BMIslope always varied signi®cantly with changes in cardiovascular risk factors such as systolic and diastolic blood pressure, total cholesterol, HDL cholesterol, triglyceride and uric acid in the expected directions. These results indicate that long-term weight gain is associated with worsening in cardiovascular risk factors, whereas long-term weight loss leads to an improvement in cardiovascular risk factors. Our ®ndings are consistent with results of other studies. 12,20 ± 22 Excluding the subjects who began medication for hypertension, dyslipidemia, hyperuricemia or diabetes mellitus during the course of the study may have biased the results toward the null. This is particularly an issue for the weight variability analyses that failed to reach statistical signi®cance. In this study, age differed signi®cantly at`0.001 between two groups (meanAE s.d.; 43.3 AE 4.1 y for 44 subjects excluded from this study and 39.1 AE 6.7 y for 580 subjects included in this study). However, there were no signi®cant differences among the values of baseline BMI, BMI-slope and BMI-RMSE and the percentage of those who cycled at b4 kg between 44 subjects excluded and 580 subjects included: 23.8 AE 2.5 and 23.3AE 2.6 kgam 2 for baseline BMI, 0.02AE 0.16 and 0.06AE 0.17 kga(m 2 ay) for BMI-slope; 0.50 AE 0.23 and 0.48AE 0.12 kgam 2 for BMI-RMSE; and 0% and 6.2% for the percentage of those who cycled at b4 kg, respectively. We therefore believe that the in¯uence of excluding the subjects who began medication for respective diseases or disorders on baseline BMI, BMI-slope, BMI-RMSE, or weight variability at b4 kg was not very strong.
Our data do not fully explain why weight cycling and weight loss are associated with increased cardiovascular mortality as reported in a number of studies. 1 ± 6 The reported adverse effects of weight cycling and loss on cardiovascular mortality remain puzzling, particularly in light of the generally favorable improvement in risk factors associated with weight loss (as re¯ected by BMI) in our study.
Our results indicate that weight variability might be associated with changes in hemoglobin A 1c , but that concerns about the hazards of dieting-related weight Table 5 Results of multiple linear regression analyses (b) examining the association between variables related to body mass index and cardiovascular risk factor slopes in 580 nonsmoking men, 1990 ± 1998 ¯uctuations are presently premature with respect to blood pressure, serum lipids and uric acid. We conclude that weight gainaloss has a much greater effect on cardiovascular risk factors than does weight cycling.
